Nephrology consultations incorporated into HIV care – non-compliance is an important issue

References

• Bakowska, E., Matlosz, B., Firlag-Burkacka, E., Kowalska, J. D., & Horban, A. (2015). Discontinuation of tenofovir due to nephrotoxicity: Insight into 12 years of clinical practice. Poster PE 11/8. 15th European AIDS conference, Barcelona, Spain.
   Google Scholar
• Campbell, L. J., Ibrahim, F., Fisher, M., Holt, S. G., Hendry, B. M., & Post, F. A. (2009). Spectrum of chronic kidney disease in HIV-infected patients. HIV Medicine, 10(6), 329–336. doi:10.1111/j.1468-1293.2008.00691.x
   PubMed Web of Science ®Google Scholar
• Del Palacio, M., Romero, S., & Casado, J. L. (2012). Proximal tubular renal dysfunction or damage in HIV-infected patients. AIDS Reviews, 14(3), 179–187.
   PubMed Web of Science ®Google Scholar
• Franceschini, N., Napravnik, S., Eron, J. J.Jr, Szczech, L. A., & Finn, W. F. (2005). Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. Kidney International, 67(4), 1526–1531. doi:10.1111/j.1523-1755.2005.00232.x
   PubMed Web of Science ®Google Scholar
• Gagneux-Brunon, A., Delanaye, P., Maillard, N., Fresard, A., Basset, T., Alamartine, E., … Mariat, C. (2013). Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort. AIDS (London, England), 27(10), 1573–1581. doi:10.1097/QAD.0b013e32835fac30
   PubMed Web of Science ®Google Scholar
• Gallant, J. E., Parish, M. A., Keruly, J. C., & Moore, R. D. (2005). Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 40(8), 1194–1198. doi:10.1086/428840
   PubMed Web of Science ®Google Scholar
• Garin, N., Velasco, C., De Pourcq, J. T., Lopez, B., Gutierrez, M. D. M., Haro, J. M., … Trilla, A. (2015). Recreational drug use among individuals living with HIV in Europe: Review of the prevalence, comparison with the general population and HIV guidelines recommendations. Frontiers in Microbiology, 6, 690. doi:10.3389/fmicb.2015.00690
   PubMed Web of Science ®Google Scholar
• Hara, M., Suganuma, A., Yanagisawa, N., Imamura, A., Hishima, T., & Ando, M. (2015). Atazanavir nephrotoxicity. Clinical Kidney Journal, 8(2), 137–142. doi:10.1093/ckj/sfv015
   PubMed Web of Science ®Google Scholar
• Hartle, P. M., Carlo, M. E., Dwyer, J. P., & Fogo, A. B. (2013). AKI in an HIV patient. Journal of the American Society of Nephrology: JASN, 24(8), 1204–1208. doi:10.1681/ASN.2012070665
   PubMed Web of Science ®Google Scholar
• Jabłonowska, E., Wójcik, K., & Małolepsza, E. (2011). The assessment of renal function in HIV-1 positive patients during antiretroviral therapy. HIV & AIDS Review, 10(2), 40–43. doi:10.1016/j.hivar.2011.02.004
   Google Scholar
• Jotwani, V., Li, Y., Grunfeld, C., Choi, A. I., & Shlipak, M. G. (2012). Risk factors for ESRD in HIV-infected individuals: Traditional and HIV-related factors. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 59(5), 628–635. doi:10.1053/j.ajkd.2011.10.050
   PubMed Web of Science ®Google Scholar
• Kimeu, M., Burmen, B., Audi, B., Adega, A., Owuor, K., Arodi, S., … Zielinski-Gutierrez, E. (2016). The relationship between adherence to clinic appointments and year-one mortality for newly enrolled HIV infected patients at a regional referral hospital in Western Kenya, January 2011–December 2012. AIDS Care, 28(4), 409–415. doi:10.1080/09540121.2015.1109587
   PubMed Web of Science ®Google Scholar
• MacPherson, P., Munthali, C., Ferguson, J., Armstrong, A., Kranzer, K., Ferrand, R. A., & Ross, D. A. (2015). Service delivery interventions to improve adolescents’ linkage, retention and adherence to antiretroviral therapy and HIV care. Tropical Medicine & International Health: TM & IH, 20(8), 1015–1032. doi:10.1111/tmi.12517
   PubMed Web of Science ®Google Scholar
• McClure, M., Singh, G. J., Rayment, M., Jones, R., & Levy, J. B. (2012). Clinical outcomes of a combined HIV and renal clinic. Clinical Kidney Journal, 5(6), 530–534. doi:10.1093/ckj/sfs141
   PubMedGoogle Scholar
• Mocroft, A., Lundgren, J. D., Ross, M., Law, M., Reiss, P., Kirk, O., … Ryom, L. (2015). Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Medicine, 12(3), e1001809. doi:10.1371/journal.pmed.1001809
   PubMed Web of Science ®Google Scholar
• Nadkarni, G. N., Konstantinidis, I., & Wyatt, C. M. (2014). HIV and the aging kidney. Current Opinion in HIV and AIDS, 9(4), 340–345. doi:10.1097/COH.0000000000000067
   PubMed Web of Science ®Google Scholar
• Praditpornsilpa, K., Avihingsanon, A., Chaiwatanarat, T., Chaiyahong, P., Wongsabut, J., Ubolyam, S., … Phanuphak, P. (2012). Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients. AIDS (London, England), 26(14), 1781–1788. doi:10.1097/QAD.0b013e328356480d
   PubMed Web of Science ®Google Scholar
• Roling, J., Schmid, H., Fischereder, M., Draenert, R., & Goebel, F. D. (2006). HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 42(10), 1488–1495. doi:10.1086/503566
   PubMed Web of Science ®Google Scholar
• Ryom, L., Mocroft, A., Kirk, O., Worm, S. W., Kamara, D. A., Reiss, P., … Lundgren, J. D. (2013). Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: The D:A:D study. The Journal of Infectious Diseases, 207(9), 1359–1369. doi:10.1093/infdis/jit043
   PubMed Web of Science ®Google Scholar
• Szczech, L. A., Gupta, S. K., Habash, R., Guasch, A., Kalayjian, R., Appel, R., … Winston, J. A. (2004). The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney International, 66(3), 1145–1152. doi:10.1111/j.1523-1755.2004.00865.x
   PubMed Web of Science ®Google Scholar
• Szymanek-Pasternak, A., Marchewka, Z., Szymańska, B., Filipowski, H., Długosz, A., Zalewska, M., & Knysz, B. (2014). Assessment of the usefulness of β2-microglobulin and retinol binding protein for the purpose of testing kidney function in HIV-positive patients. HIV & AIDS Review, 13(2), 40–45. doi:10.1016/j.hivar.2014.02.006
   Google Scholar
• Yombi, J. C., Pozniak, A., Boffito, M., Jones, R., Khoo, S., Levy, J., & Post, F. A. (2014). Antiretrovirals and the kidney in current clinical practice: Renal pharmacokinetics, alterations of renal function and renal toxicity. AIDS (London, England), 28(5), 621–632. doi:10.1097/QAD.0000000000000103
   PubMed Web of Science ®Google Scholar